Superior survival using living donors and donor-recipient matching using a novel living donor risk index

Hepatology

Volumn 60, Issue 5, 2014, Pages 1717-1726

  Goldberg, David S ^a,b,c   French, Benjamin ^b,c   Abt, Peter L ^b   Olthoff, Kim ^b   Shaked, Abraham ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; CHOLESTATIC LIVER DISEASE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; LIVING DONOR RISK INDEX; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; COMPARATIVE STUDY; MULTIVARIATE ANALYSIS; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION; TREATMENT OUTCOME;

FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 84922221440     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27307     Document Type: Article

References (25)

1. Goldberg DS, French B, Thomasson A, Reddy KR, Halpern SD. Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation 2011;91:1148-1152.
2. Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transpl 2004;4:1302-1307.
3. Patt CH, Thuluvath PJ. Adult living donor liver transplantation. Med Gen Med 2003;5:26.
4. Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology. 2007;133:1806-1813.
5. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011;54:1313-1321.
6. Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Freise CE, Shaked A, et al. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant 2012;12:2997-3007.
7. Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, et al. Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl 2011;17:789-797.
8. Martin P DA, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014;59:1144-1165.
9. Shah SA, Levy GA, Greig PD, Smith R, McGilvray ID, Lilly LB, et al. Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing. Am J Transplant 2007;7:998-1002.
10. Axelrod DA, McCullough KP, Brewer ED, Becker BN, Segev DL, Rao PS. Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation. Am J Transpl 2010;10(4 Pt 2):987-1002.
11. Haberal M, Abbasoglu O, Buyukpamukcu N, Bilgin N, Telatar H, Simsek H, et al. Combined liver-kidney transplantation from a living-related donor. Transplant Proc 1993;25:2211-2213.
12. Glidden DV, Vittinghoff E. Modelling clustered survival data from multicentre clinical trials. Stat Med 2004;23:369-388.
13. Asrani SK, Kim WR, Edwards EB, Larson JJ, Thabut G, Kremers WK, et al. Impact of the center on graft failure after liver transplantation. Liver Transpl 2013;19:957-964.
14. Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol 2011;55:808-813.
15. Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg V, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery 2009;146:543-552; discussion 552-543.
16. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transpl 2006;6:783-790.
17. French B, Saha-Chaudhuri P, Ky B, Cappola TP, Heagerty PJ. Development and evaluation of multi-marker risk scores for clinical prognosis. Stat Methods Med Res 2012.
18. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337-344.
19. Halpern SD. Donation after circulatory determination of death: time for transparency. Ann Emerg Med 2013.
20. Halpern SD, Barnes B, Hasz RD, Abt PL. Estimated supply of organ donors after circulatory determination of death: a population-based cohort study. JAMA 2010;304:2592-2594.
21. Goldberg DS, Halpern SD, Reese PP. Deceased organ donation consent rates among racial and ethnic minorities and older potential donors. Crit Care Med 2013;41:496-505.
22. Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, et al. Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant 2012;12:1208-1217.
23. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008;135:468-476.
24. Hall EC, Boyarsky BJ, Deshpande NA, Garonzik_Wang JM, Berger JC, Dagher NN, et al. Perioperative complications after live-donor hepatectomy. JAMA Surg 2014;149:288-291.
25. Bramstedt KA. Living liver donor mortality: where do we stand? Am J Gastroenterol 2006;101:755-759.